In two out of three BCC patients (B-04 and B-06), the majority of tumor-infiltrating MAIT cell clones after anti-PD-1 therapy were novel – that is they were not detected in pre-treatment samples. This evidence concerns the gene PDCD1 and skin basal cell carcinoma.